VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TDOC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TDOCTeladoc Health, Inc.
$8.69$1.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTDOCBalance Sheet

Teladoc Health, Inc. (TDOC) Balance Sheet

13Y historyFree accessUpdated daily

The company maintains a $1.0 billion debt load against negative retained earnings of $16.5 billion, indicating a capital structure heavily reliant on external financing.

TDOC Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13
Total Current Assets1.13B1.09B1.66B1.49B1.29B1.23B1.06B588M532.74M156.24M82.72M151.58M54.66M6.83M
Cash & Short-Term Investments750.74M781.08M1.3B1.12B918.18M896.02M786.57M517.06M478.53M122.31M65.81M137.35M46.44M3.21M
Cash Only750.74M781.08M1.3B1.12B918.18M893.48M733.32M514.35M423.99M42.82M50.02M55.07M46.44M3.21M
Short-Term Investments000002.54M53.24M2.71M54.55M79.49M15.79M82.28M00
Accounts Receivable213.63M201.66M223.96M230.06M235.65M190.12M169.28M56.95M43.57M27.09M13.81M12.13M7.09M2.86M
Days Sales Outstanding31.5329.0931.8132.2735.7434.1456.4837.5738.0542.3940.9257.2359.4752.5
Inventory31.56M38.2M38.14M29.51M56.34M73.08M56.5M0000000
Days Inventory Outstanding15.618.0718.5314.1727.6441.0252.76-------
Other Current Assets136.42M2.07M36.02M40.15M12.1M27.96M0010.63M6.84M02.1M08K
Total Non-Current Assets1.67B2.01B1.85B2.9B3.42B16.51B16.7B1.01B996.14M668.15M220.95M78.16M37.34M20.56M
Property, Plant & Equipment50.51M53.09M56.58M72.09M71.47M74.01M75.2M36.75M10.15M8.96M7.48M6.26M1.06M331K
Fixed Asset Turnover46.55x47.65x45.42x36.10x33.68x27.46x14.55x15.06x41.18x26.03x16.47x12.36x40.87x60.14x
Goodwill283.19M283.19M283.19M1.07B1.07B14.5B14.58B746.08M737.2M498.52M188.18M56.34M28.45M14.79M
Intangible Assets1.24B1.3B1.43B1.68B1.84B1.91B2.02B225.45M247.39M159.81M24.88M15.27M7.53M5.35M
Long-Term Investments0000000094.01M49.4M0000
Other Non-Current Assets106.04M137.62M81.49M80.26M78.5M20.7M18.36M6.54M1.4M858K415K293K296K93K
Total Assets2.81B3.1B3.52B4.39B4.7B17.73B17.76B1.6B1.53B824.39M303.67M229.74M92.01M27.39M
Asset Turnover0.86x0.82x0.73x0.59x0.51x0.11x0.06x0.35x0.27x0.28x0.41x0.34x0.47x0.73x
Asset Growth %-66.61%-11.82%-19.94%-6.56%-73.49%-0.12%1007.75%4.84%85.46%171.48%32.18%149.7%235.96%-
Total Current Liabilities404.87M404.74M941.53M420.62M399.77M331.01M332.65M90.18M62.44M40.33M21.07M17.99M13.02M5.14M
Accounts Payable45.2M47.97M33.13M43.64M47.69M47.26M46.03M9.07M7.77M3.88M2.24M2.21M2.21M67K
Days Payables Outstanding21.0922.6916.120.9623.426.5342.9917.9622.0323.0125.5338.3981.245.84
Short-Term Debt011.04M550.72M013.59M042.56M0002M1.25M833K0
Deferred Revenue (Current)272.86M62.3M79.3M95.66M101.83M75.57M52.36M12.46M7.65M4.11M1M831K5.44M0
Other Current Liabilities233.29M187.17M69.33M167.26M151.28M132.21M128.92M39.26M16.54M12.05M5.93M5.52M6.62M3.27M
Current Ratio2.80x2.69x1.77x3.54x3.22x3.70x3.19x6.52x8.53x3.87x3.93x8.43x4.20x1.33x
Quick Ratio2.72x2.59x1.73x3.47x3.07x3.48x3.02x6.52x8.53x3.87x3.93x8.43x4.20x1.33x
Cash Conversion Cycle26.0424.4734.2525.4839.9848.6366.26-------
Total Non-Current Liabilities1.07B1.31B1.08B1.65B1.99B1.36B1.54B498.62M453.32M225.16M51.73M33.19M25.75M3.19M
Long-Term Debt995.81M994.92M991.42M1.54B1.54B1.23B1.38B440.41M414.68M207.37M42.42M25.23M25.2M3M
Capital Lease Obligations135.79M34.2M32.13M42.84M38.04M41.77M43.14M24.99M000000
Deferred Tax Liabilities363.06M271.44M49.85M49.45M406.54M75.78M102.1M21.68M32.44M12.91M1.69M1.19M494K102K
Other Non-Current Liabilities551K643K720K1.08M1.62M10.78M11.54M9.24M6.19M17.79M7.61M6.78M62K88K
Total Liabilities1.47B1.72B2.03B2.07B2.39B1.69B1.87B588.8M515.76M265.49M72.8M51.17M38.78M8.33M
Total Debt1.03B1.04B1.58B1.59B1.59B1.28B1.48B470.49M414.68M207.37M44.42M26.48M26.03M3M
Net Debt276.81M259.08M286.29M468.6M668.74M386.65M743.41M-43.86M-9.31M164.55M-5.59M-28.59M-20.41M-212K
Debt / Equity0.77x0.75x1.06x0.68x0.69x0.08x0.09x0.46x0.41x0.37x0.19x0.15x0.49x0.16x
Debt / EBITDA24.40x10.38x-286.33x----------
Net Debt / EBITDA6.57x2.59x-84.27x----------
Interest Coverage-8.76x-10.95x-8.77x-9.45x-9.91x-2.95x-6.98x-2.51x-2.53x-3.56x-20.30x-23.65x-9.69x-101.23x
Total Equity1.34B1.39B1.49B2.33B2.31B16.05B15.88B1.01B1.01B558.9M230.87M178.56M53.23M19.05M
Equity Growth %-26.41%-7.07%-35.9%0.79%-85.62%1.02%1466.41%0.09%81.27%142.09%29.29%235.45%179.35%-
Book Value per Share7.467.868.7414.1314.29102.24175.4914.1115.3910.085.458.971.930.69
Total Shareholders' Equity1.34B1.39B1.49B2.33B2.31B16.05B15.88B1.01B1.01B558.9M230.87M178.56M53.23M19.05M
Common Stock180K178K173K167K163K160K150K73K70K61K46K38K27K2.85M
Retained Earnings-16.49B-16.43B-16.23B-15.23B-15.01B-1.42B-992.66M-507.52M-408.66M-311.58M-204.73M-130.51M-72.49M-55.45M
Treasury Stock00000000000000
Accumulated OCI-35.42M-34.73M-38.39M-36.99M-42.78M-6.29M18.52M-17.24M-13.07M4.09M-1K-42K-1.26M-927K
Minority Interest00000000000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetStrained
Cash FlowBurning
Top Statement Risk

Persistent Goodwill Impairment Risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Balance Sheet Erosion Amidst Contraction

As reported in recent financial filings, TDOC's total assets have declined from $4.4 billion in 2023Q4 to $2.8 billion in 2026Q1, reflecting a significant contraction in the company's resource base as it struggles to navigate a challenging competitive environment and persistent operational losses.

The consistent decline in total assets suggests that the company is shedding value, likely driven by the ongoing impairment of historical acquisitions. Investors should monitor whether this downward trajectory in asset value stabilizes or if further write-downs are required to align the balance sheet with current market realities.

Leverage Remains Elevated Despite Deleveraging

Based on the provided quarterly data, TDOC has maintained a debt load of $1.0 billion as of 2026Q1, which, when viewed against the backdrop of negative retained earnings of $16.5 billion, suggests a capital structure that is heavily reliant on external financing to sustain operations.

While the debt-to-equity ratio has fluctuated, the persistent reliance on debt in the absence of positive net income indicates that the company's leverage is necessity-driven rather than strategic. This structure warrants further investigation into the company's ability to service these obligations if cash flow generation continues to deteriorate.

Liquidity Buffer Faces Increasing Pressure

According to the latest balance sheet figures, the company's cash position has decreased from $1.3 billion in 2024Q4 to $750.7 million in 2026Q1, signaling a tightening liquidity buffer that may limit management's flexibility to pivot or invest in new growth initiatives.

The current ratio of 2.80 appears healthy on the surface, but the rapid depletion of cash reserves suggests that the company is burning through its liquidity to fund ongoing operating losses. This trend may indicate that the company will face increased pressure to secure additional funding or drastically reduce costs.

Goodwill Impairment Masks Structural Weakness

As reported in financial statements, the massive reduction in goodwill from $1.1 billion in 2023Q4 to $283.2 million in 2026Q1 highlights the significant destruction of shareholder value associated with past M&A activity, which continues to distort the company's headline book value and equity quality.

The substantial write-downs suggest that the company's historical capital allocation strategy was fundamentally flawed, leading to an overstatement of assets in prior periods. Investors should be cautious, as the remaining goodwill may still be subject to further impairment if the current business model fails to achieve profitability.

TDOC — Frequently Asked Questions

Quick answers to the most common questions about buying TDOC stock.

What are the total assets of Teladoc Health, Inc. (TDOC)?

As of 2025, Teladoc Health, Inc. (TDOC) had total assets of $3.10B including $1.09B in current assets.

How much debt does Teladoc Health, Inc. (TDOC) have?

Teladoc Health, Inc. (TDOC) carries total debt of $1.04B, offset by $781.1M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Teladoc Health, Inc.?

Teladoc Health, Inc. (TDOC) has total shareholders' equity (book value) of $1.39B ($7.86 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Teladoc Health, Inc.'s current ratio and liquidity?

Teladoc Health, Inc. (TDOC) reported a current ratio of 2.69x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.